North America Cancer Vaccines Market cover

North America Cancer Vaccines Market by Technology (Recombinant Cancer Vaccines, Whole-cell Cancer Vaccines, Viral Vector, DNA Cancer Vaccines, and Other Technology), Treatment Methods (Preventive Vaccine and Therapeutic Vaccine), Applications (Prostate Cancer, Cervical Cancer, and Other Applications), and Geography (Canada, The US, Mexico, and Rest of North America) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: CG-2333
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 194
  • Format:
  • Pub. Date: Upcoming
  • Share:

The North America cancer vaccines market size is expected to register a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the technological advancements in the healthcare sector.

North America Cancer Vaccines Market  summary

Vaccines can be utilized in treatment of cancer as it can perceive protein that are available for particular cancer cells. Cancer vaccines provide various advantages as it can stop the development of dangerous cells, prevents cancer relapse and obliterate malignancy cells that are abandoned after cancer treatment. A wide range of vaccine are used for the treatment of cancer such as antigen vaccines, which boost the immune system instead of using whole tumor cells that can be targeted to specific cancer type. Vector-based antibodies can be utilized to convey more than one cancer antigen at a time.

Constant advancement by manufacturers for improvement of new immunizations is relied upon new vaccines, which is expected to boost the growth of the global cancer vaccines market.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing demand for vaccines to meet unmet requirements is expected to upsurge the market growth.
  • Rising occurrence of cancer such as cervical cancer, prostate cancer, breast cancer, and lung cancer globally is expected to fuel the growth of global cancer vaccines market during the forecast period.
  • Rising investments and government funding is estimated to fuel the growth of the market in North America.
  • High development cost and longer time incurred in the development of vaccines  can hinder the market growth.
  • Innovations focusing on development of effective and specific cancer treatment is anticipated to create new opportunities for major players in the cancer vaccines market during the forecast period.

Scope of the Report

The report on the North America cancer vaccines market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes Details

Report Title

North America Cancer Vaccines Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Technology (Recombinant Cancer Vaccines, Whole-cell Cancer Vaccines, Viral Vector, DNA Cancer Vaccines, and Other Technology), Treatment Methods (Preventive Vaccine and Therapeutic Vaccine), Applications (Prostate Cancer, Cervical Cancer, and Other Applications)

Geographical Scope

Canada, The US, Mexico, and Rest of North America

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Astellas Pharma Inc.; Merck & Co. Inc.; GlaxoSmithKline; Bristol-Myers Squibb; and Amgen Inc.

North America Cancer Vaccines Market Segment Insights

Recombinant Cancer Vaccines segment is expected to grow at a rapid pace

Based on technology, the market is divided into recombinant cancer vaccines, whole-cell cancer vaccines, viral vector, DNA cancer vaccines, and other technology. The recombinant cancer vaccines segment is expected to grow at a rapid pace during the forecast period. Rising utilization of recombinant vaccines, increasing adoption of recombinant technology to develop cancer vaccines are the key factors that can boost the growth of the market segment.

North America Cancer Vaccines Market technology

Preventive vaccines segment is projected to expand at a healthy CAGR

On the basis of treatment methods, the market is segregated into preventive vaccine and therapeutic vaccine. The preventive vaccine segment is projected to expand at a considerable CAGR during the forecast period. Preventive vaccines work by preventing infectious agents that cause or contribute to the development of cancer. Two types of disease avoidance antibodies endorsed by the US Food and Drug Administration (FDA) that incorporate the human papillomavirus immunization (HPV) and hepatitis B immunization.

Prostate cancer segment is anticipated to account a major market share

In terms of applications, the market is segmented into prostate cancer, cervical cancer, and other applications. The prostate cancer segment is estimated to account for a major market share owing to increasing case of prostate cancer in women globally.

The US is anticipated to constitute a key market share

In terms of regions, the North America cancer vaccines market is classified as Canada, the US, Mexico, and Rest of North America. The US is expected to constitute a key share of the market during the forecast period. This is attributed to the presence of dominant players in the market and well developed healthcare infrastructure in the country. 

North America Cancer Vaccines Market geography

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cancer Vaccines Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Cancer Vaccines Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Cancer Vaccines Market - Supply Chain
  4.5. Global Cancer Vaccines Market Forecast
     4.5.1. Cancer Vaccines Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Cancer Vaccines Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Cancer Vaccines Market Absolute $ Opportunity
5. Global Cancer Vaccines Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Cancer Vaccines Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Cancer Vaccines Demand Share Forecast, 2019-2026
6. North America Cancer Vaccines Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Cancer Vaccines Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Cancer Vaccines Demand Share Forecast, 2019-2026
7. Latin America Cancer Vaccines Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Cancer Vaccines Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Cancer Vaccines Demand Share Forecast, 2019-2026
8. Europe Cancer Vaccines Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Cancer Vaccines Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Cancer Vaccines Demand Share Forecast, 2019-2026
9. Asia Pacific Cancer Vaccines Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Cancer Vaccines Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Cancer Vaccines Demand Share Forecast, 2019-2026
10. Middle East & Africa Cancer Vaccines Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Cancer Vaccines Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Cancer Vaccines Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Cancer Vaccines Market: Market Share Analysis
  11.2. Cancer Vaccines Distributors and Customers
  11.3. Cancer Vaccines Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Astellas Pharma Inc.
     11.4.2. Merck & Co. Inc.
     11.4.3. GlaxoSmithKline
     11.4.4. Bristol-Myers Squibb
     11.4.5. Amgen Inc.

Segments Covered in the Report

The North America cancer vaccines market has been segmented on the basis of

Technology

  • Recombinant Cancer Vaccines
  • Whole-cell Cancer Vaccines
  • Viral Vector
  • DNA Cancer Vaccines
  • Other Technology

Treatment Methods

  • Preventive Vaccine
  • Therapeutic Vaccine

Applications

  • Prostate Cancer
  • Cervical Cancer
  • Other Applications

Geography

  • Canada
  • The US
  • Mexico
  • Rest of North America

Key Players

  • Astellas Pharma Inc.
  • Merck & Co. Inc.
  • GlaxoSmithKline
  • Bristol-Myers Squibb
  • Amgen Inc.

Key players competing in the North America cancer vaccines market are Astellas Pharma Inc.; Merck & Co. Inc.; GlaxoSmithKline; Bristol-Myers Squibb; and Amgen Inc.

Some of the market players are adopting strategies such as merger, acquisition, partnership, collaboration, and capacity expansion to enhance their market position.

North America Cancer Vaccines Market keyplayers

Buy Report